Vivek Jeevakumar
University of Texas at Dallas
11 Papers
Vivek Jeevakumar is an academic researcher from University of Texas at Dallas. The author has contributed to research in topics: Parvalbumin & Nociceptor. The author has an hindex of 7, co-authored 11 publications. Previous affiliations of Vivek Jeevakumar include University of Alabama at Birmingham.
Chat about Author
Papers
Ketamine Administration During the Second Postnatal Week Alters Synaptic Properties of Fast-Spiking Interneurons in the Medial Prefrontal Cortex of Adult Mice
Vivek Jeevakumar,Sven Kroener +1 more
TL;DR: Developmental ketamine treatment resulted in an increased NMDA:AMPA ratio in evoked synaptic currents and larger amplitudes of spontaneous NMDAR currents, indicating a homeostatic upregulation of N MDARs in PV interneurons.
Convergence of peptidergic and non-peptidergic protein markers in the human dorsal root ganglion and spinal dorsal horn
Stephanie Shiers,Ishwarya Sankaranarayanan,Vivek Jeevakumar,Anna Cervantes,Jeffrey C. Reese,Theodore J. Price +5 more
TL;DR: The protein distribution of nociceptor markers, including their central projections, in the human DRG and spinal cord is assessed, consistent with the known polymodal nature of most primate nocICEptors and indicate that the central projection patterns of nOCiceptors are different between mice and humans.
49
Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction.
Kazuhito Nakao,Kazuhito Nakao,Vivek Jeevakumar,Sunny Zhihong Jiang,Yuko Fujita,Noelia Belen Diaz,Carlos Alfredo Pretell Annan,Karen L. Eskow Jaunarajs,Kenji Hashimoto,Juan E. Belforte,Kazu Nakazawa,Kazu Nakazawa +11 more
TL;DR: It is suggested that PV GABAergic neuron-NMDAR hypofunction in postnatal development confers bidirectional NAc hyper- and mPFC hypo-sensitivity to amphetamine-induced dopamine release, similar to that classically observed in schizophrenia pathophysiology.
40
Antioxidant Treatment in Male Mice Prevents Mitochondrial and Synaptic Changes in an NMDA Receptor Dysfunction Model of Schizophrenia.
Aarron Phensy,Christopher Driskill,Karen A. Lindquist,Lan Guo,Vivek Jeevakumar,Bryan Fowler,Heng Du,Sven Kroener +7 more
- 01 Jul 2017
TL;DR: The ability of NAC to prevent or restore changes in synaptic transmission at pyramidal cells and PVIs that result from developmental NMDAR blockade supports the usefulness of antioxidant supplementation in the treatment of schizophrenia.
35
Monkey and Rat Prefrontal Cortex Parvalbumin-Positive Basket Interneurons in
S. Krimer,N. V. Povysheva,Aleksey V. Zaitsev,Diana C. Rotaru,G. Gonzalez-Burgos,Deborah Ann Lewis,Vivek Jeevakumar,Sven Kroener,Christian Koelbl,Moritz Helmstaedter,Joachim H. R. Lübke,Dirk Feldmeyer,David A. Lewis,Guillermo Gonzalez-Burgos,Diana C. Rotaru,Takeaki Miyamae,Nadezhda V. Povysheva +16 more
- 01 Jan 2015